Risk stratification for inhibitor development at first treatment for severe hemophilia A: a tool for clinical practice.

Translated title of the contribution: Risk stratification for inhibitor development at first treatment for severe hemophilia A: a tool for clinical practice.

P.C. ter Avest, K. Fischer, M.E. Mancuso, E. Santagostino, V.J. Yuste, H.M. van den Berg, the CANAL Study Group On behalf of, J.G. van der Bom

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionRisk stratification for inhibitor development at first treatment for severe hemophilia A: a tool for clinical practice.
Original languageUndefined/Unknown
Pages (from-to)2048-2054
Number of pages7
JournalJournal of Thrombosis and Haemostasis
Volume6
Issue number12
Publication statusPublished - 2008

Cite this